Pharmaceutical compositions comprising insulin sensitivity enhancer and another antidiabetic
CA 2533845 C · Owner: Takeda Chemical Industries, Ltd. · Inventors: Sohda, Takashi; Ikeda, Hitoshi; Odaka, Hiroyuki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is a pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with another antidiabetic differing from the enhances in the mechanism of action other than a biguanide and an insulin secretion enhances and which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 20, 1996 and granted October 9, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 20, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 20, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.